MarketPeel
Insider Trading Intelligence
Pricing
…
RI

Rachid Izzar

BIIB
HEAD OF GLOBAL PRODUCT STRAT. · BIOGEN INC. · CIK 0001875506
FILING MIX · LIFETIME36%/64%
BUYS
27
SELLS
49
TOTAL VALUE
$2.40M
COMPANIES
1
ACTIVE SINCE
Dec 2021
HOLDINGS NOW
7,390
AVG SELL PX
$206.64
TRADE KIND
SHOWING 76 / 76
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Rachid Izzar, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-5.18%+0.29%-5.47%-5.47%—
14d1+100.00%-4.92%+1.37%-6.29%-6.29%—
30d1+100.00%-4.99%+1.92%-6.91%-6.91%—
60d1+0.00%+4.62%+4.34%+0.28%+0.28%—
90d1+0.00%+14.57%+8.27%+6.30%+6.30%—
180d1+0.00%+29.88%+10.86%+19.01%+19.01%—
1y1(1 pending)——————
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BIIB · 7,390 shares · as of Feb 13, 2026
02,9475,8938,84011,78620222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 27 buys / 49 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
7,390——7,390Feb 13, 2026Feb 17, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
1,802——1,802Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
1,802——9,201Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
2,044——0Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
458$201.18$92.1K8,743Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
3,043——11,786Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
775$201.18$155.9K11,011Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
2,044——8,204Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
3,043——6,087Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
805$201.18$161.9K7,399Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE10b5-1
10b5-1 plan
2,223$135.00$300.1K6,330Jul 8, 2025Jul 16, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
1,515——0Feb 10, 2025Feb 12, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
1,515——8,998Feb 10, 2025Feb 12, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
445$142.54$63.4K8,553Feb 10, 2025Feb 12, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
1,801——3,604Feb 7, 2025Feb 11, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
1,801——7,860Feb 7, 2025Feb 11, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
2,043——7,224Feb 7, 2025Feb 11, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
600$141.35$84.8K6,624Feb 7, 2025Feb 11, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
565$141.35$79.9K6,059Feb 7, 2025Feb 11, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
2,043——2,044Feb 7, 2025Feb 11, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
9,130——9,130Feb 6, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
1,370——10,006Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
639$219.08$140.0K9,367Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
1,370——0Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
313$219.08$68.6K9,701Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
807——0Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
647——10,014Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
647——807Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
445$240.98$107.2K8,636Feb 9, 2024Feb 13, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
1,515——1,515Feb 9, 2024Feb 13, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
1,515——9,081Feb 9, 2024Feb 13, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
2,043——8,187Feb 8, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
2,043——4,087Feb 8, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
621$240.30$149.2K7,566Feb 8, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
5,405——5,405Feb 7, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
1,370——1,370Jan 29, 2024Jan 31, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
244$284.85$69.5K6,144Jun 30, 2023Jul 5, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
504——0Jun 30, 2023Jul 5, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
504——6,388Jun 30, 2023Jul 5, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
681——1,454Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
767——5,884Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
767——2,135Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
371$278.38$103.3K5,117Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
1,515——6,359Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
220$286.30$63.0K6,130Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Global Product Strat.
453——6,350Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
453——553Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
1,515——3,030Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
462$286.30$132.3K5,897Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
553——0Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Global Product Strat.
642$286.30$183.8K5,488Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
6,130——6,130Feb 8, 2023Feb 10, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
1,783——4,844Jan 25, 2023Jan 27, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
1,285——0Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
570$298.90$170.4K2,825Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
425——433Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
433——0Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Alzheimer's Disease
425——3,250Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
189$298.90$56.5K3,061Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Alzheimer's Disease
1,285——3,395Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
148$210.63$31.2K2,110Jul 1, 2022Jul 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
504——504Jul 1, 2022Jul 6, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Alzheimer's Disease
504——2,258Jul 1, 2022Jul 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
854——2,902Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
594——3,756Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Alzheimer's Disease
594——1,929Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
175$209.79$36.7K1,754Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
122$214.59$26.2K1,335Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Alzheimer's Disease
351——1,457Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
651——1,006Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
351——1,657Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
4,545——4,545Feb 10, 2022Feb 14, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
484——858Dec 2, 2021Dec 6, 2021 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
165$228.52$37.7K1,106Dec 2, 2021Dec 6, 2021 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Alzheimer's Disease
372——1,342Dec 2, 2021Dec 6, 2021 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Alzheimer's Disease
372$228.52$85.0K1,271Dec 2, 2021Dec 6, 2021 ↗View →
Other insiders · BIIB
Loading peer insiders…
About this filer
CIK 0001875506
ROLE
Head of Global Product Strat.
PRIMARY
BIIB
COMPANIES
1
ACTIVE SINCE
Dec 2021
MARKETPEEL · /INSIDER/0001875506DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback